Bancos A, Iancu S, Moisoiu V, Ghiaur A, Tigu A, Buran C
J Cell Mol Med. 2025; 29(5):e70244.
PMID: 40042091
PMC: 11880916.
DOI: 10.1111/jcmm.70244.
Dai L, Johnson-Buck A, Laird P, Tewari M, Walter N
Anal Chem. 2024; 96(43):17209-17216.
PMID: 39425638
PMC: 11648273.
DOI: 10.1021/acs.analchem.4c03002.
Bronkhorst A, Holdenrieder S
Med Genet. 2024; 35(4):201-235.
PMID: 38835739
PMC: 11006350.
DOI: 10.1515/medgen-2023-2065.
Hassan J, Saeed S, Deka L, Jasim Uddin M, Das D
Pharmaceutics. 2024; 16(2).
PMID: 38399314
PMC: 10892549.
DOI: 10.3390/pharmaceutics16020260.
Little R, Snowton M, Uziel O
Heliyon. 2024; 10(1):e23519.
PMID: 38170065
PMC: 10758867.
DOI: 10.1016/j.heliyon.2023.e23519.
DoSurvive: A webtool for investigating the prognostic power of a single or combined cancer biomarker.
Wu H, Wu J, Yeh Y, Wu T, Chao C, Wang W
iScience. 2023; 26(8):107269.
PMID: 37609633
PMC: 10440714.
DOI: 10.1016/j.isci.2023.107269.
Detection of Circulating Tumor DNA in Plasma Using Targeted Sequencing.
Sun X, Liu X, Zhao Y, Tian G, Wang W
Methods Mol Biol. 2023; 2695:27-46.
PMID: 37450110
DOI: 10.1007/978-1-0716-3346-5_3.
Impact of Circulating Cell-Free DNA (cfDNA) as a Biomarker of the Development and Evolution of Periodontitis.
Viglianisi G, Santonocito S, Polizzi A, Troiano G, Amato M, Zhurakivska K
Int J Mol Sci. 2023; 24(12).
PMID: 37373135
PMC: 10298201.
DOI: 10.3390/ijms24129981.
A high-throughput test enables specific detection of hepatocellular carcinoma.
Cheishvili D, Wong C, Karim M, Kibria M, Jahan N, Chandra Das P
Nat Commun. 2023; 14(1):3306.
PMID: 37286539
PMC: 10247794.
DOI: 10.1038/s41467-023-39055-7.
A Self-attention Graph Convolutional Network for Precision Multi-tumor Early Diagnostics with DNA Methylation Data.
Jiang X, Li Z, Mehmood A, Wang H, Wang Q, Chu Y
Interdiscip Sci. 2023; 15(3):405-418.
PMID: 37247186
DOI: 10.1007/s12539-023-00563-1.
Targeting altered glycosylation in secreted tumor glycoproteins for broad cancer detection.
Kudelka M, Gu W, Matsumoto Y, Ju T, Barnes Ii R, Kardish R
Glycobiology. 2023; 33(7):567-578.
PMID: 37216646
PMC: 10426321.
DOI: 10.1093/glycob/cwad035.
Development of a Point-of-Care Cervico-Vaginal Sampling/Testing Device for the Colorimetric Detection of Cervical Cancer.
Appidi T, Vakada M, Buddhiraju H, Chinchulkar S, Kota A, Yadav D
Diagnostics (Basel). 2023; 13(8).
PMID: 37189483
PMC: 10137237.
DOI: 10.3390/diagnostics13081382.
Shifting the Cancer Screening Paradigm: The Rising Potential of Blood-Based Multi-Cancer Early Detection Tests.
Brito-Rocha T, Constancio V, Henrique R, Jeronimo C
Cells. 2023; 12(6).
PMID: 36980276
PMC: 10047029.
DOI: 10.3390/cells12060935.
Rapid detection of cancer DNA in human blood using cysteamine-capped AuNPs and a machine learning-enabled smartphone.
Koowattanasuchat S, Ngernpimai S, Matulakul P, Thonghlueng J, Phanchai W, Chompoosor A
RSC Adv. 2023; 13(2):1301-1311.
PMID: 36686949
PMC: 9814906.
DOI: 10.1039/d2ra05725e.
Prognostic value of TMEM59L and its genomic and immunological characteristics in cancer.
Shi C, Zhang L, Chen D, Wei H, Qi W, Zhang P
Front Immunol. 2023; 13:1054157.
PMID: 36618425
PMC: 9816415.
DOI: 10.3389/fimmu.2022.1054157.
Nanoscale Investigation of DNA Demethylation in Leukemia Cells by Means of Ultrasensitive Vibrational Spectroscopy.
Onaciu A, Toma V, Moldovan C, Tigu A, Cenariu D, Culic C
Sensors (Basel). 2023; 23(1).
PMID: 36616944
PMC: 9823440.
DOI: 10.3390/s23010346.
Multiomics characteristics and immunotherapeutic potential of EZH2 in pan-cancer.
Luo L, Wang Z, Hu T, Feng Z, Zeng Q, Shu X
Biosci Rep. 2022; 43(1).
PMID: 36545914
PMC: 9842950.
DOI: 10.1042/BSR20222230.
New Perspectives on the Importance of Cell-Free DNA Biology.
Bronkhorst A, Ungerer V, Oberhofer A, Gabriel S, Polatoglou E, Randeu H
Diagnostics (Basel). 2022; 12(9).
PMID: 36140548
PMC: 9497998.
DOI: 10.3390/diagnostics12092147.
Development of label-free gold nanoparticle based rapid colorimetric assay for clinical/point-of-care screening of cervical cancer.
Appidi T, Mudigunda S, Kodandapani S, Rengan A
Nanoscale Adv. 2022; 2(12):5737-5745.
PMID: 36133887
PMC: 9419083.
DOI: 10.1039/d0na00686f.
Differentiating between liver diseases by applying multiclass machine learning approaches to transcriptomics of liver tissue or blood-based samples.
Listopad S, Magnan C, Asghar A, Stolz A, Tayek J, Liu Z
JHEP Rep. 2022; 4(10):100560.
PMID: 36119721
PMC: 9472076.
DOI: 10.1016/j.jhepr.2022.100560.